On Monday, the Financial Times reported that the White House may bypass standard Food and Drug Administration (FDA) regulations to fast-track the use of the so-called Oxford coronavirus vaccine.
On Monday, the Financial Times reported that the White House may bypass standard Food and Drug Administration (FDA) regulations to fast-track the use of the so-called Oxford coronavirus vaccine.
